Recent Advances in Fe-MOF Compositions for Biomedical Applications
- PMID: 33992053
- DOI: 10.2174/0929867328666210511014129
Recent Advances in Fe-MOF Compositions for Biomedical Applications
Abstract
Background: To date, number of new and attractive materials have been applied in drug delivery systems (DDDs) to improve the efficiency of the treatment of cancers. Some problems like low stability, toxicity and weak ability of targeting have hampered most of materials for further applications in biomedicine. MIL(MIL = Materials of Institute Lavoisier), as a specific subclass of metal-organic frameworks (MOFs) owns more advantages than other subclass MOFs, such as better biodegradability and lower cytotoxicity. However, until now, systematic -s and analyses of Fe-based MIL on medical applications are rarely though the majority of documents discussed one research branch of the porous materials MOFs.
Discussion: In this review, we have focussed mainly on the latest studies of applications, including bioimaging, biosensing, and antibacterial and drug delivery on Fe-based MIL. The existing shortcomings and future perspectives of the rapidly growing biomedical applications of Fe-based MIL materials addressing dosage and loading strategies issues are also discussed briefly, and further studies with the use of different therapies will be of great interest.
Conclusion: This article reviews the Fe-based MOFs design and biomedical application, including biosensing, bioimaging, antibacterial agent, and drug delivery in recent years.
Keywords: DDS; Fe-based MOF; MIL; MOF; biomedical applications; cancer..
Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.
Similar articles
-
Current status and prospects of MIL-based MOF materials for biomedicine applications.RSC Med Chem. 2023 Sep 1;14(10):1914-1933. doi: 10.1039/d3md00397c. eCollection 2023 Oct 18. RSC Med Chem. 2023. PMID: 37859709 Free PMC article. Review.
-
Recent Advances in Metal-Organic Frameworks as Anticancer Drug Delivery Systems: A Review.Anticancer Agents Med Chem. 2021;21(18):2487-2504. doi: 10.2174/1871520621666210119093844. Anticancer Agents Med Chem. 2021. PMID: 33463479 Review.
-
Metal-Organic Frameworks for Biomedical Applications.Small. 2020 Mar;16(10):e1906846. doi: 10.1002/smll.201906846. Epub 2020 Feb 6. Small. 2020. PMID: 32026590 Review.
-
Metal Organic Framework (MOF) Particles as Potential Bacteria-Mimicking Delivery Systems for Infectious Diseases: Characterization and Cellular Internalization in Alveolar Macrophages.Pharm Res. 2019 Feb 21;36(4):53. doi: 10.1007/s11095-019-2589-4. Pharm Res. 2019. PMID: 30790066
-
Iron-MOFs for Biomedical Applications.Adv Healthc Mater. 2025 Mar;14(8):e2402630. doi: 10.1002/adhm.202402630. Epub 2024 Oct 10. Adv Healthc Mater. 2025. PMID: 39388416 Free PMC article. Review.
Cited by
-
Metal-based nano-delivery platform for treating bone disease and regeneration.Front Chem. 2022 Aug 9;10:955993. doi: 10.3389/fchem.2022.955993. eCollection 2022. Front Chem. 2022. PMID: 36017162 Free PMC article. Review.
-
Layered Double Hydroxides: Recent Progress and Promising Perspectives Toward Biomedical Applications.Adv Sci (Weinh). 2024 May;11(20):e2306035. doi: 10.1002/advs.202306035. Epub 2024 Mar 19. Adv Sci (Weinh). 2024. PMID: 38501901 Free PMC article. Review.
-
Hyaluronic acid-anchored nanoparticles co-delivering emodin and siRNA confers protection against rheumatoid arthritis via macrophage polarization.Mater Today Bio. 2025 Jul 10;33:102074. doi: 10.1016/j.mtbio.2025.102074. eCollection 2025 Aug. Mater Today Bio. 2025. PMID: 40688667 Free PMC article.
-
Recent Advances of Fe(III)/Fe(II)-MPNs in Biomedical Applications.Pharmaceutics. 2023 Apr 23;15(5):1323. doi: 10.3390/pharmaceutics15051323. Pharmaceutics. 2023. PMID: 37242566 Free PMC article. Review.
-
Current status and prospects of MIL-based MOF materials for biomedicine applications.RSC Med Chem. 2023 Sep 1;14(10):1914-1933. doi: 10.1039/d3md00397c. eCollection 2023 Oct 18. RSC Med Chem. 2023. PMID: 37859709 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
- 51978415/Natural Science Foundation of China
- GDMUZ2019008/Science Foundation of Guangdong Medical University
- 2019KTSCX052, 2019KTSCX053/Featured Innovation Project of Guangdong Province
- PDJH2020B0265, PDJH2020A0252, PDJH2020B0260, PDJH2020B0267/Special Funds for Scientific Technological Innovation of Undergraduates in Guangdong Province
- 2019A1515110260/Guangdong Basic and Applied Basic Research Foundation
LinkOut - more resources
Full Text Sources
Other Literature Sources